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Chemistry
Unless otherwise noted, all solvents and reagents for organic synthesis were obtained from commercial suppliers and were used without further purification. All reactions were carried out under a dry Ar atmosphere with anhydrous, freshly distilled solvents under anhydrous conditions unless otherwise noted. All reactions were stirred with Teflon-coated magnetic stir bars, and temperatures were measured externally. Reactions requiring anhydrous conditions were carried out in oven-dried (120 o C, 24 h) or flame-dried (vacuum <0.5 Torr) glassware. Yields refer to chromatographically and spectroscopically ( 1 H NMR) homogeneous materials. Reactions were monitored by thin-layer chromatography (TLC) carried out on 0.25 mm silica gel plates (60 F254, E. Merck). Silica gel (60, particle size: 0.040-0.063 mm, E. Merck) was used for flash column chromatography.
NMR spectra were recorded on a Bruker Avance DRX-500 instrument at 298 K using NMR 1 H-1 H COSY and 1 H-13 C HMQC correlation spectra were also recorded at 298 K in order to assist the peak assignment. Quantitation of the final compounds was achieved using an internal standard of 2,5-dimethylfuran (DMFu, 0.1 mM in MeOD). S1 High-resolution mass spectra (HRMS) were measured on Agilent 6224 Accurate Mass TOF LC/MS at the Faculty of Chemistry and Chemical Technology, University of Ljubljana.
(S)-methyl 4-amino-3-(2-(tert-butoxycarbonylamino)-4-phenylbutanamido)benzoate (3).
A mixture of methyl 3,4-diaminobenzoate (500 mg, 3.0 mmol) and (S)-2-(tertbutoxycarbonylamino)-4-phenylbutanoic acid (920 mg, 3.3 mmol), O-(benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (HBTU, 2.27 g, 6.0 mmol) and N,Ndiisopropylethylamine (DIEA, 1.57 mL, 9.0 mmol) in anhydrous DMF (12 mL, 0.25 mM) was stirred under Ar atmosphere at ambient temperature for 4 h. The mixture was then diluted in EtOAc (60 mL) and washed sequentially with aqueous HCl 1.0 N (20 mL), sat. NaHCO 3 (20 mL) and sat. NaCl (30 mL). Consequently, the solvent was evaporated under reduced pressure to provide the crude product, which was eluted from a gradient of 40% to 80% EtOAc in hexanes to yield 3 as colorless oil (1.05 g, 82% 166.9, 156.5, 146.5, 140.8, 129.5, 128.6, 128.5 128.4, 126.2, 121.5, 119.3, 115.6, 80.5, 55.0, 51.7, 33.8, 32.0, 28.4 (S)-4-amino-3-(2-(tert-butoxycarbonylamino)-4-phenylbutanamido)benzoic acid (4).
Compound 3 (470 mg, 1.1 mmol) was dissolved in 20 mL dioxane and then 22 mL aqueous LiOH 1.0 M (22 mmol, 20 eq.) were added under rigorous stirring. After 4 h at ambient temperature the mixture was diluted with 8 mL aqueous sat. NaCl and the organic solvent was evaporated. The remaining aqueous solution (pH~12) was extracted with EtOAc (20 mL) and then acidified with HCl 1.0 N until no further precipitation was observable (pH~2 158.3, 150.0, 142.3, 131.1, 130.8, 129.5, 129.5, 127.1, 122.0, 119.3, 115.8, 80.9, 56.5, 34.7, 33.2, 28 .7.
General procedure for coupling of 4 with O-protected amino acids (Method A).
A mixture of 4 (50 mg, 0.12 mmol), the O-protected amino acid (0.18 mmol, 1.5 eq.), HBTU (95 mg, 0.25 mmol) and DIEA (70 µL, 0.40 mmol) in anhydrous DMF (0.5 mL, 0.25 mM) was stirred under Ar atmosphere at ambient temperature for 12 h. The reaction mixture was then diluted in EtOAc (25 mL) and washed sequentially with aqueous HCl 1.0 N (10 mL), sat.
NaHCO 3 (10 mL) and sat. NaCl (15 mL). Consequently, the solvent was evaporated under reduced pressure to provide the crude product, which was purified using a gradient of EtOAc in hexanes to yield the desired product in yields of 72-92%. 4, 171.9, 166.8, 156.9, 145.2, 140.9, 128.5, 128.5, 128.5, 128.5, 126.9, 126.1, 125.5, 123.0, 121.9, 116.3, 80.5, 54.9, 52.6, 48.5, 34.2, 32.2, 28.4, 28.4, 28.4, 17.9 (S)-benzyl 2-(4-amino-3-((S)-2-(tert-butoxycarbonylamino)-4-phenylbutanamido)benzamido)-3-methylbutanoate (6). 170.2, 158.3, 148.7, 142.4, 137.2, 129.5, 129.4, 129.3, 128.7, 128.3, 127.1, 123.0, 122.1, 116.1, 80.8, 67.7, 60.2, 56.5, 34.8, 33.2, 31.7, 28.7, 19.6, 19 .2
Reaction of

(2S,3R)-methyl 2-(4-amino-3-((S)-2-(tert-butoxycarbonylamino)-4-phenylbutanamido) benzamido)-3-hydroxybutanoate (7).
Reaction of 4 with (2S,3R)-methyl 2-amino-3-hydroxybutanoate (L-Thr-OMe) using Method A 4, 172.3, 167.6, 156.8, 145.2, 140.8, 128.5, 127.5, 126.2, 125.2, 122.9, 121.7, 116.6, 80.7, 68.1, 58.3, 54.9, 52.6, 34.3, 32.2, 28.3, 20 .0
(S)-methyl 2-(4-amino-3-((S)-2-(tert-butoxycarbonylamino)-4-phenylbutanamido) benzamido)-6-(tert-butoxycarbonylamino)hexanoate (8).
Reaction of 4 with (S)-methyl 2-amino-6-(tert-butoxycarbonylamino)hexanoate (L-Lys(Boc)- 0, 172.0, 167.0, 156.8, 156.3, 145.1, 140.9, 128.6, 127.3, 126.3, 125.2, 123.3, 122.0, 116.7, 80.7, 79.2, 54.9, 52.6, 52.5, 40.4, 34.5, 32.2, 31.8, 29.7, 28.5, 28.4, 23 .0
(S)-methyl 2-(4-amino-3-((S)-2-(tert-butoxycarbonylamino)-4-phenylbutanamido) benzamido)-5-((Z)-2,3-bis(benzyloxycarbonyl)guanidino)pentanoate (9).
Reaction of 4 with (S,Z)-methyl 2-amino-5-(2,3-bis(benzyloxycarbonyl)guanidino)pentanoate (LArg(Z) 2 -OMe) using Method A afforded 9 in yield of 72%. R f =0.55 (70% EtOAc/Hexanes 3, 171.7, 167.0, 162.1, 156.6, 155.7, 151.6, 149.4, 145.2, 140.8, 135.1, 131.1, 129.6, 128.9, 128.8, 128.7, 128.5, 128.4, 128.3, 128.1, 128.0, 127.9, 126.9, 126.2, 125.8, 123.1, 121.1, 120.9, 116.0, 115.5, 111.5, 80.5, 69.0, 67.1, 54.9, 52.5, 52.3, 44.4, 34.1, 33.8, 32.0, 28.4, 25 .1
(S)-methyl 2-(4-amino-3-((S)-2-(tert-butoxycarbonylamino)-4-phenylbutanamido) benzamido)-3-(4-tert-butoxyphenyl)propanoate (10).
Reaction of 4 with (S)-methyl 2-amino-3-(4-tert-butoxyphenyl)propanoate (L-Tyr(O-tBu)-OMe)
using Method A afforded 10 in yield of 78%. R f =0.50 (70% EtOAc/Hexanes 171.5, 166.6, 156.6, 154.4, 145.0, 140.8, 131.2, 129.8, 128.7, 128.6, 126.8, 126.4, 125.7, 124.3, 123.6, 122.3, 116.5, 80.7, 78.6, 54.9, 54.0, 52.4, 37.3, 34.0, 32.2, 29 .0, 28.5
(S)-benzyl 2-(4-amino-3-((S)-2-(tert-butoxycarbonylamino)-4-phenylbutanamido) benzamido)-3-(1H-indol-3-yl)propanoate (11).
Reaction of 4 with (S)-benzyl 2-amino-3-(1H-indol-3-yl)propanoate (L-Trp-OBn) using Method 167.0, 156.6, 145.3, 140.9, 136.3, 135.5, 128.7, 128.7, 128.6, 128.5, 128.4, 127.5, 126.8, 126.3, 126.0, 123.5, 123.1, 122.1, 121.7, 119.5, 118.5, 116.1, 111.6, 109.7, 80.7, 67.3, 54.9, 53.4, 34.0, 32.1, 28.4, 27.6 6
General procedure for deprotection of O-Bn and N-Cbz group (Method B).
The desired compound (~0.1 mmol) was dissolved in MeOH (4 mL, ~0.025 mM) and the solution was degassed under Ar atmosphere. A catalytic amount of activated Pd/C 10% was added and degassed under Ar and then H 2 . The mixture was stirred under H 2 at ambient temperature for 1 h, then filtered and washed with MeOH. The resulting product was acquired in yields of 90-95%
and was used without any further purification.
General procedure for deprotection of N-Boc and Ο-tBu groups (Method C).
The desired compound (~0.1 mmol) was dissolved in a mixture of CH 2 Cl 2 /TFA (2:1 mL, ~0.03 mM) and stirred at ambient temperature for 30 min. Consequently, the solvents were evaporated and the product was treated with HCl 1.0 N (0.5 mL). The solvents were evaporated using toluene (2 × 2 mL) and dried under vacuum overnight to yield the hydrochloric salt of the terminal α-amine in yields of ~ 97% without any further purification.
(S)-methyl 2-(4-amino-3-((S)-2-amino-4-phenylbutanamido)benzamido)propanoate (12).
Deprotection of the N-Boc group of 5 using Method C yielded 12. 169.6, 169.4, 146.9, 141.3, 129.7, 129.7, 129.3, 129.3, 128.5, 127.7, 127.5, 123.9, 122.5, 117.2, 54.8, 52.7, 50.1, 34.8, 32.2, 17 3, 170.1, 169.6, 147.8, 141.3, 137.2, 129.7, 129.7, 129.5, 129.5, 129.4, 129.4, 129.3, 129.3, 129.3, 128.6, 127.8, 127.6, 123.7, 122.0, 116.7, 67.8, 60.3, 54.8, 34.8, 32.2, 31.7, 19.6, 19 
(S)-2-(4-amino-3-((S)-2-amino-4-phenylbutanamido)benzamido)-3-methylbutanoic acid (14).
Deprotection of the O-Bn group of 6 using Method B, and subsequent deprotection of the N-Boc group using Method C yielded 14. 
(S)-methyl 6-amino-2-(4-amino-3-((S)-2-amino-4-phenylbutanamido)benzamido)hexanoate (16).
Deprotection of both N-Boc
(S)-6-amino-2-(4-amino-3-((S)-2-amino-4-phenylbutanamido)benzamido)hexanoic acid (17).
Hydrolysis of the methyl ester of 8 as described for 4, and subsequent deprotection of the two N- 5, 176.8, 169.3, 147.5, 143.2, 129.5, 129.5, 129.5, 129.5, 127.0, 126.8, 126.7, 123.9, 122.2, 116.4, 56.8, 56.6, 42.5, 40.4, 34.0, 33.8, 33.5, 24.3 
(S)-methyl 2-(4-amino-3-((S)-2-amino-4-phenylbutanamido)benzamido)-5-guanidino pentanoate (18).
Deprotection of the guanidine N-Cbz groups of 9 using Method B, and subsequent deprotection of the N-Boc group using Method C yielded 18. 168.2, 167.8, 158.6, 146.4, 141.3, 130.1, 129.6, 129.5, 129.4, 128.8, 128.1, 127.5, 126.9, 124.8, 123.6, 55.1, 54.2, 52.9, 41.9, 34.3, 32 
(S)-methyl 2-(4-amino-3-((S)-2-amino-4-phenylbutanamido)benzamido)-3-(4-hydroxyphenyl)
propanoate (19). 169.5, 157.3, 147.6, 141.3, 131.2, 131.2, 129.8, 129.8, 129.3, 129.3, 129.1, 128.4, 127.7, 127.6, 123.5, 122.1, 116.8, 116.8, 116.3, 116.3, 56.1, 54.7, 52.7, 37.5, 34.8, 32 8, 169.6, 169.5, 147.9, 141.3, 138.0, 137.1, 129.8, 129.8, 129.5, 129.5, 129.3, 129.3, 129.2, 129.2, 129.2, 128.8, 128.4, 127.8, 127.6, 124.4, 123.3, 122.5, 121.9, 119.9, 119.2, 116.7, 112.4, 110.8, 67.9, 55.8, 54.8, 34.8, 32.2, 28.4 0, 167.3, 151.2, 141.3, 137.6, 130.1, 129.7, 129.4, 128.9, 128.3, 127.8, 127.6, 122.5, 55.0, 52.8, 34.5, 32 168.4, 148.3, 141.2, 136.1, 130.5, 129.8, 129.4, 129.1, 128.3, 128.0, 127.6, 122.3, 55.0, 34.5, 32.2 Recombinant enzyme production and purification enzymes was found to be >95% by SDS-PAGE.
Enzyme activity assay
The enzymatic activity of ERAP1, ERAP2 and IRAP were determined by following the hydrolysis of the synthetic substrates L-Leucine-7-amido-4-methyl coumarin for ERAP1 and IRAP (L-AMC; Sigma) and L-Arginyl-7-amido-4-methyl coumarin for ERAP2 (R-AMC; Sigma), monitored by the release of the fluorogenic product, AMC, at excitation and emission wavelengths of 380 and 460 nm, respectively.
All measurements were performed on a TECAN infinite ® M200 microplate fluorescence reader. For evaluation of inhibitory activity, 2-7 nM of each enzyme (6.2 nM of ERAP1, 2.5 nM of ERAP2 and 2.6 nM of IRAP), diluted in 50 mM HEPES (pH 7.0), 100 mM NaCl buffer, was added in each well, along with 50 µM of substrate and various concentrations of each compound. The reaction was followed for 5-10 min and activity was calculated by measuring the slope of the time course.
For calculation of the in vitro IC 50 values, experimental data were fit to the following equation using the GraphPad Prism software package:
Y=Bottom + (Top-Bottom)/(1+10^((LogIC 50 -X)*HillSlope))
where: Y is the enzymatic activity and X the inhibitor concentration. Standard deviation was calculated from 3 separate experiments.
The activity of ERAP1 was also measured using the chromogenic substrate LLeucine-para-nitroanilide (L-pNA) by following the absorbance of the enzymatic product para-nitroanilide (pNA) at 405 nm (extinction coefficient=9450 M -1 cm -1 ) during incubation with ERAP1. Briefly, 1.5 µg ml −1 ERAP1 was incubated at room temperature with increasing concentrations of L-pNA (in the 0-10 mM range) in 50 mM HEPES, pH 7.0, 100 mM NaCl, for 5-10 min. The rate of hydrolysis was calculated by the slope of the time-dependent increase in absorbance. For Michaelis-Menten calculations, initial reaction rates were plotted versus different substrate concentrations and were fit to a standard Michaelis-Menten model (using the GraphPad Prism software). 
HPLC analysis
Analysis of digestion products after incubation of compounds with ERAP1 was performed by RP-HPLC on a Chromolith C-18 analytical column (Merck). In brief, 10 µM of each peptide was incubated at room temperature with 50 nM ERAP1 in 50 mM HEPES pH 7.0, 100 mM NaCl buffer in a total volume of 200 µl for 7-30 min. After incubation, the reactions were terminated by adding 200 µl 0.1% trifluoroacetic acid and stored at -20°C until analysis.
Before analysis, samples were centrifuged for 5 min at 10,000 g to remove precipitated protein.
HPLC elution was performed using a 0-50% acetonitrile gradient, while following the absorbance at 257 nm. 
Computational methods
In an effort to gain insight into the structure-activity relationships of the designed inhibitors, molecular docking was employed. The crystallographic structures of ERAP1 15 and ERAP2 16 in the closed conformation were retrieved from the Protein Data Bank with accession codes 2YD0 and 3SE6, respectively. To prepare the structures for the docking calculations a set of programs from AMBER 11 package were used. S2 Hydrogen and missing atoms were added, and the improved ff99SB S3 force field parameters were applied using the XLEaP module. The missing loop regions that are ~30 Å away from the active-site zinc ion were not modeled. Acidic and basic residues were set to their ionized state, except for the histidine residues that were set to their neutral state. Force field parameters and the charge distribution of the Zn 2+ coordination sphere were taken from ref. S4 . To optimize the position of the modeled atoms and relax the structures from crystallographic contacts a two-step minimization procedure was carried out in implicit solvent using a pairwise generalized Born model implemented in Amber (igb=1). S5 In the first round of minimization, only hydrogen atoms were allowed to relax by applying positional restraints on all heavy atoms, while in the second round, positional restraints were applied only on the C α atoms. The non-bonded interactions were not truncated using the effectively infinite default value for the cutoff, the positional restraints were applied with a force constant of 50 kcal mol −1 Å −2 , and the convergence criterion for the energy gradient was decreased to 10 -3 kcal mol −1 Å −1 . A homology model for IRAP was obtained as described in ref.
17, but using both ERAP1 and ERAP2 energy-minimized structures as templates.
The initial conformations of the designed inhibitors were generated from SMILES representations using the program Omega 2.3 with default parameters. S6,S7 Input files for docking were prepared using AutoDockTools 1.5.4 S8 Initially, non-polar hydrogens were merged and then either Kollman or Gasteiger charges were applied for the protein and ligand atoms, respectively.
The search space was defined by a grid box centered close to the active-site zinc and comprised 121×101×121 grid points of 0.25 Å spacing. For each complex, 100 docking rounds were calculated with AutoDock 4.2 using the Lamarckian genetic algorithm with the default parameters from AutoDock 3. S9,S10 The maximum number of energy evaluations was set to 5 million and the results were clustered using a tolerance of 2.0 Å. Visual examination of the results and rendering of the figures was performed using VMD 1.9. S11 Calculations were carried out using Intel Xeon servers running Linux 2.6.32 kernels.
